ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia
Thomas Ernst(Jena University Hospital), M. C. Muller(Heidelberg University)
Cited by 50